Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Giffhorn's 200,000 shares:

The shares aren't preferred, they are restricted. IMO, that means they are common shares that have restrictions on when they can be issued to him or when they can be sold. For example, maybe a portion of the shares are issued to him on prescribed dates.

I assume that his share price is as of November 1, or somewhere around that. So .... $0.44/share.

Share
New Message
Please login to post a reply